We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.45B
AUM Growth
+$379M
Cap. Flow
+$62.7M
Cap. Flow %
1.15%
Top 10 Hldgs %
26.99%
Holding
161
New
18
Increased
65
Reduced
42
Closed
14

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$43.7M
2
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$39.4M
3
LAD icon
Lithia Motors
LAD
+$30.5M
4
PANW icon
Palo Alto Networks
PANW
+$25.7M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$25.5M

Top Sells

Rank Stock Value
1
GTM
ZoomInfo Technologies
GTM
+$82.3M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$41.8M
3
IMVT icon
Immunovant
IMVT
+$40M
4
DV icon
DoubleVerify
DV
+$35.4M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$34.4M

Sector Composition

Rank Sector Weight
1 Healthcare 43.08%
2 Technology 23.47%
3 Industrials 13.06%
4 Consumer Discretionary 7.01%
5 Utilities 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
51
Royalty Pharma
RPRX
$26.2B
$37.8M 0.69%
1,049,113
+300,690
+40% +$11.1M
DDOG icon
52
Datadog
DDOG
$95.6B
$36M 0.66%
495,232
-10,694
-2% -$785K
ENPH icon
53
Enphase Energy
ENPH
$4.94B
$36M 0.66%
171,081
+1,000
+0.6% +$217K
NVT icon
54
nVent Electric
NVT
$23.4B
$34.5M 0.63%
802,503
-42,553
-5% -$1.79M
KDNY
55
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$33.3M 0.61%
1,439,564
+1,070,753
+290% +$25.5M
CDW icon
56
CDW
CDW
$18.6B
$33.1M 0.61%
169,795
+14,628
+9% +$2.87M
APLS
57
DELISTED
Apellis Pharmaceuticals
APLS
$32.7M 0.6%
495,000
+155,645
+46% +$8.98M
NARI
58
DELISTED
Inari Medical, Inc. Common Stock
NARI
$31.7M 0.58%
512,914
+163,203
+47% +$9.79M
VECT
59
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$31.6M 0.58%
3,675,644
+270,000
+8% +$2.23M
CCI icon
60
Crown Castle
CCI
$33.4B
$31.5M 0.58%
235,052
-122,274
-34% -$16.9M
SNPS icon
61
Synopsys
SNPS
$71.3B
$30.8M 0.56%
79,712
+15,341
+24% +$5.48M
IRTC icon
62
iRhythm Holdings
IRTC
$3.91B
$29.7M 0.54%
239,135
– –
LAD icon
63
Lithia Motors
LAD
$9.24B
$28.7M 0.53%
+125,499
New +$30.5M
COGT icon
64
Cogent Biosciences
COGT
$7.07B
$27.9M 0.51%
2,589,778
– –
PRVA icon
65
Privia Health
PRVA
$3.01B
$27.6M 0.51%
1,000,000
– –
PLD icon
66
Prologis
PLD
$136B
$27.2M 0.5%
218,216
+157,750
+261% +$19.4M
BEPC icon
67
Brookfield Renewable
BEPC
$6.04B
$27.1M 0.5%
775,403
+384
+0% +$11.6K
STE icon
68
Steris
STE
$22.5B
$26.1M 0.48%
136,516
-2,929
-2% -$566K
ORLY icon
69
O'Reilly Automotive
ORLY
$72.4B
$25.8M 0.47%
456,360
+453,540
+16,083% +$24.8M
SRPT icon
70
Sarepta Therapeutics
SRPT
$1.64B
$25.8M 0.47%
+187,268
New +$24.3M
INSP icon
71
Inspire Medical Systems
INSP
$1.44B
$25.3M 0.46%
108,220
– –
AURA icon
72
Aura Biosciences
AURA
$735M
$23.4M 0.43%
2,525,830
+274,462
+12% +$2.85M
XENE icon
73
Xenon Pharmaceuticals
XENE
$6.2B
$22.9M 0.42%
641,200
– –
AJG icon
74
Arthur J. Gallagher & Co
AJG
$65.9B
$22.9M 0.42%
119,758
+27,676
+30% +$5.25M
TRGP icon
75
Targa Resources
TRGP
$57.6B
$22.8M 0.42%
312,949
+173,388
+124% +$12.8M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Eventide Asset Management held 161 positions worth $5.45B, up 7.5% from $5.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management's Q1 2023 filing shows 18 new, 65 increased, 42 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 125,499 shares worth $28.7M. The largest sale was ZoomInfo Technologies, an estimated $82.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2023 buy was Lithia Motors: 125,499 shares worth $28.7M.
  • Eventide Asset Management added most to Doximity in Q1 2023, an estimated $43.7M increase.
  • Eventide Asset Management's biggest Q1 2023 reduction was ZoomInfo Technologies, cutting an estimated $82.3M.
  • Eventide Asset Management fully exited Bicycle Therapeutics in Q1 2023, selling an estimated $25.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $5.45B portfolio in Q1 2023.
  • Eventide Asset Management opened 18 new positions and closed 14 in Q1 2023.
  • Eventide Asset Management's portfolio value rose 7.5% quarter-over-quarter to $5.45B.

Based on Eventide Asset Management's 13F filing for Q1 2023, filed 15 May 2023.